For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Interferon pathway snippet

Interferon signaling pathway

Related

  • ​Immunology and infectious disease hub
    • Information and products associated with novel coronavirus research
      • Products associated with key targets involved in coronavirus research
        • All interactive pathways

          Get an overview of the canonical and non-canonical interferon signaling pathways involved in the host antiviral response with our interactive pathway poster.

          Published 10 June, 2021

          Download your interferon pathway poster here

          Interferons (IFNs) are powerful cytokines and key components in the first line of defense against viral infections1. They control the inflammation and immune response by directly inducing anti-pathogen molecular countermeasures that can inhibit virus replication2.

          There are three types of IFNs (type I, II, and III) involved in fighting a viral infection. Type I and III IFNs are expressed by immune and tissue-specific cells in response to a viral infection and share important antiviral properties2,3. 

          Canonical pathways

          In the canonical pathways, interactions between type I and II IFN and their respective receptors IFNAR1/2 and IFNLR1/IL10R2 induce conformational changes, leading to activation of the receptor-associated Janus kinase (JAK) family (JAK1, JAK2, and TYK2). This activation allows for the recruitment and phosphorylation of signal transducer and activator of transcription (STAT) proteins.

          The phosphorylated STATs will then dimerize and associate with IRF9 to form the IFN-stimulated gene factor 3 (ISGF3) complex. Upon translocation to the nucleus, this complex acts as transcription factors, regulating IFN-stimulated gene (ISG) expression2. Viruses, like SARS-CoV-2 or Influenza, possess structural and non-structural viral proteins that can disrupt the type I IFN canonical signaling pathway4. 

          Non-canonical pathways

          In non-canonical pathways against viral infections, unphosphorylated STATs can form the unphosphorylated- ISG factor 3 (ISGF3) complex, which induces the expression of the ISG responsible for keeping cells protected from viral infections for longer2. Additionally, the CrkL:pSTAT-5 complex, formed between Crk-like protein and phosphorylated STAT5, translocates to the nucleus and regulates gene transcription via IFN-γ activated site (GAS) elements5.

          What to expect from our IFN pathway poster

          • See an overview of the canonical and non-canonical IFN signaling pathways involved in the host antiviral response
          • Discover the proteins involved in these pathways
          • Find highly validated products to your targets of interest

          References

          1. Sadler A.J. and Williams B.R.G. 2008. Interferon-inducible antiviral effectors. Nat Rev Immunol, 8(7):559-68.
          2. Stanifer M.L., Pervolaraki K., Boulant S, 2019. Differential Regulation of Type I and Type III Interferon Signaling. Int J Mol Sci, 20(6):1445.
          3. Hervas-Stubbs S, Perez-Gracia J.L., Rouzaut A. , Sanmamed M.F., Le Bon A.L., and Melero I, 2011. Direct Effects of Type I Interferons on Cells of the Immune System. Clin Cancer Res, 17 (9): 2619-2627
          4. Yang E and Li MMH, 2020. All About the RNA: interferon-stimulated Genes that interfere with viral RNA processes. Front Immunol, 11: 605024.
          5. Mazewski Candice, Perez Ricardo E., Fish Eleanor N. and Platanias Leonidas C, 2020. Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signalling Pathways . Front Immunol 11: 3025
          Get resources and offers direct to your inbox Sign up
          A-Z by research area
          • Cancer
          • Cardiovascular
          • Cell biology
          • Developmental biology
          • Epigenetics & Nuclear signaling
          • Immunology
          • Metabolism
          • Microbiology
          • Neuroscience
          • Signal transduction
          • Stem cells
          A-Z by product type
          • Primary antibodies
          • Secondary antibodies
          • Biochemicals
          • Isotype controls
          • Flow cytometry multi-color selector
          • Kits
          • Loading controls
          • Lysates
          • Peptides
          • Proteins
          • Slides
          • Tags and cell markers
          • Tools & Reagents
          Help & support
          • Support
          • Make an Inquiry
          • Protocols & troubleshooting
          • Placing an order
          • RabMAb products
          • Biochemical product FAQs
          • Training
          • Browse by Target
          Company
          • Corporate site
          • Investor relations
          • Company news
          • Careers
          • About us
          • Blog
          Events
          • Tradeshows
          • Conferences
          International websites
          • abcam.cn
          • abcam.co.jp

          Join with us

          • LinkedIn
          • facebook
          • Twitter
          • YouTube
          • Terms of sale
          • Website terms of use
          • Cookie policy
          • Privacy policy
          • Legal
          • Modern slavery statement
          © 1998-2023 Abcam plc. All rights reserved.